Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy (vol 117, pg 1656, 2017)

被引：3

作者：

Braadland, Peder R.

Giskeodegard, Guro

Sandsmark, Elise

Bertilsson, Helena

Euceda, Leslie R.

Hansen, Ailin F.

Guldvik, Ingrid J.

Selnaes, Kirsten M.

Grytli, Helene H.

Katz, Betina

Svindland, Aud

Bathen, Tone F.

Eri, Lars M.

Nygard, Stale

Berge, Viktor

Tasken, Kristin A.

Tessem, May-Britt

机构：

来源：

BRITISH JOURNAL OF CANCER | 2018年 / 118卷 / 06期

关键词：

D O I：

10.1038/bjc.2017.470

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Correction to: British Journal of Cancer (2017) 117, 1656–1664. doi:10.1038/bjc.2017.346; published online 3 October 2017 There is an error in final paragraph of the Discussion. The correct sentence is: In summary, low concentration of spermine and high tChoCre/Spm ratio, determined by HR-MAS MRS ofprostate cancer tissue, were associated with shorter time to recurrence.

引用

页码：e11 / e11

页数：1

共 1 条

[1] Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy [J].

Braadland, Peder R. ;

Giskeodegard, Guro ;

Sandsmark, Elise ;

Bertilsson, Helena ;

Euceda, Leslie R. ;

Hansen, Ailin F. ;

Guldvik, Ingrid J. ;

Selnaes, Kirsten M. ;

Grytli, Helene H. ;

Katz, Betina ;

Svindland, Aud ;

Bathen, Tone F. ;

Eri, Lars M. ;

Nygard, Stale ;

Berge, Viktor ;

Tasken, Kristin A. ;

Tessem, May-Britt .

BRITISH JOURNAL OF CANCER, 2017, 117 (11) :1656-1664

← 1 →